Long-term glucagon-like peptide-1 (GLP-1) therapies combined with intensive behavioral therapy are recommended for adults ...

The success of semaglutide and tirzepatide is evident in their 2024 sales volumes and revenues, creating a clearer picture of ...

The World Health Organization is officially backing popular weight-loss drugs like Ozempic and Wegovy. The WHO published new ...

Shaily Engineering Plastics Ltd and Gland Pharma Ltd, involved in the making and filling of injectable pens for semaglutide, ...

MIT's smart implant dispenses life-saving drug when diabetics need it most By Abhimanyu Ghoshal July 10, 2025 The MIT team's glucagon implant features a drug reservoir sealed with an alloy that ...

Opko Health and Entera Bio have formalized their partnership as the biotechs prepare to take the first orally administered dual agonist glucagonlike-peptide 1 (GLP-1)/glucagon peptide into the clinic.

At Pharmapack Europe 2025 this past January, Alper Hulusi – Head of Market Insights at ClariMed, gave a Lightning Talk on ‘Designing for an Emergency: Considerations for emergency use product design.

Glucagon is a peptide hormone secreted primarily from the alpha cells of the pancreatic islets of Langerhans. Minor amounts are also produced in the L cells of the intestine and certain neurons of the ...

Pre-clinical studies demonstrated that blocking glucagon activity can improve heart function in heart failure with preserved ejection fraction (HFpEF), a type of heart disease that is notoriously ...